Home › NDC Lookup › RxCUI directory › RxCUI 1364360

Ponatinib 45 MG Oral Tablet — RxCUI 1364360

RxNorm drug concept · Semantic clinical drug
RxCUI 1364360 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1364360
Official namePonatinib 45 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asponatinib (as ponatinib hydrochloride) 45 MG Oral Tablet
FDA products mapped4
Package NDCs mapped5
Reported Medicaid activity (SDUD)2,562 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ponatinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Iclusig (ponatinib) is used to treat specific types of leukemia in adults — mainly chronic myeloid leukemia (CML) and a type called Philadelphia chromosome-positive acute lymphobla...
  • What exactly is Iclusig used for? My doctor mentioned leukemia, but there seem to be different types.
  • Good news — you can take Iclusig with or without food, whichever works best for you. It's taken once a day, and studies show that meals don't meaningfully change how much of the me...
  • Can I take Iclusig with food? Does it matter when I take it?
📖 Read our full Ponatinib guide →

🕸️ Concept Web — How Ponatinib 45 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ponatinib 45 MG Oral Tablet RxCUI 1364360

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ponatinib 1364347
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Iclusig 1364353
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ponatinib Oral Tablet 1364351
    • Ponatinib Oral Product 1364349
    • Ponatinib Pill 1364350
    • Ponatinib Oral Tablet [Iclusig] 1364355
    • Iclusig Oral Product 1364356
    • Iclusig Pill 1364357
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ponatinib 45 MG SCDC · 1364359
  • Ponatinib Oral Tablet SCDF · 1364351
  • Ponatinib Oral Product SCDG · 1364349
  • Ponatinib Pill SCDG · 1364350

Brand-Name Concepts

  • Ponatinib 45 MG Oral Tablet [Iclusig] SBD · 1364362
  • Ponatinib 45 MG [Iclusig] SBDC · 1364361
  • Ponatinib Oral Tablet [Iclusig] SBDF · 1364355
  • Iclusig Oral Product SBDG · 1364356
  • Iclusig Pill SBDG · 1364357
  • Iclusig BN · 1364353

📦 FDA Products & Package NDCs

4 products · 5 package NDCs
5 package NDCs map to RxCUI 1364360 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
63020-0533-30 30 TABLET, FILM COATED in 1 BOTTLE (63020-533-30) Iclusig Takeda Pharmaceuticals America, Inc. 2015-04-22
63020-0534-30 30 TABLET, FILM COATED in 1 BOTTLE (63020-534-30) Iclusig Takeda Pharmaceuticals America, Inc. 2012-12-14
63020-0535-30 30 TABLET, FILM COATED in 1 BOTTLE (63020-535-30) Iclusig Takeda Pharmaceuticals America, Inc. 2012-12-14
63020-0535-60 60 TABLET, FILM COATED in 1 BOTTLE (63020-535-60) Iclusig Takeda Pharmaceuticals America, Inc. 2012-12-14
63020-0536-30 30 TABLET, FILM COATED in 1 BOTTLE (63020-536-30) Iclusig Takeda Pharmaceuticals America, Inc. 2021-01-11
Observed labelers: Takeda Pharmaceuticals America, Inc. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.